Zurueck zur Suche

Reporte zur Charge UJ677AAB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 IN 1

VAERS 2613409

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ677AAB

gering
Staat
NY
Alter
0,3
Geschlecht
M
Eingang
11.04.2023
Impfdatum
11.04.2023
Beginn
11.04.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Vaccine was expired when administered on 4-11-2023. Vaccine expired 4-7-2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
URI 3-21-2023
Vorgeschichte
None
Andere Medikamente
Di Vi Sol
Allergien
NKA
Vorherige Impfungen
-

VAERS 2572861

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ677AAB

gering
Staat
IN
Alter
1,3
Geschlecht
F
Eingang
01.02.2023
Impfdatum
23.01.2023
Beginn
23.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product preparation issue

Symptomtext

just administered the diluent portion of the ACTHIB without reconstituting it with the lyophilized vaccine component with no reported adverse event; Initial information received on 27-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 months old female patient who was just administered the diluent portion of the HIB (PRP/T) Vaccine [ACT-HIB] without reconstituting it with the lyophilized vaccine component with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Jan-2023, the patient received a 0.6 ml dose of suspect diluent portion of the HIB (PRP/T) Vaccine without reconstituting it with the lyophilized vaccine component with no reported adverse event (product preparation issue) (Powder and solvent for solution for injection) (lot UJ677AAB, Expiry date: 07-Apr-2023 with strength unknown) via intramuscular route in the left thigh for immunization. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-